Alembic Pharmaceuticals Updates Registration Link for Upcoming Post-Results Earnings Call
Alembic Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 5:00 pm
Alembic Pharmaceuticals Updates Registration Link for Upcoming Post-Results Earnings Call Alembic Pharmaceuticals has issued an updated registration link for its post-results conference call with analysts and institutional investors, scheduled for 4th Nov'26 at 5:00 PM IST. Dial-in details remain unchanged, with universal access available at +91 22 6280 1411 and +91 22 7115 8312, alongside international toll-free options for the USA, UK, Singapore, and Hong Kong.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
